A Several studies have found that long-term use of anticholinergic
drugs is associated with a significantly higher risk of developing dementia, especially vascular dementia, in people over 80.
Drugs Market Outlook 2019 to 2024 : Information by Type (Synthetic Compounds, Natural, Semi-Synthetic Compounds), Application (Overactive Bladder, Parkinson's Disease, Chronic Obstructive Pulmonary Disease, Muscle Spasms, Irritable Bowel Syndrome), Route of Administration (Oral, Parenteral, Topical), End User (Hospitals and Pharmacies) and Region - Forecast till 2024
The findings come from the analysis of the brains of people taking anticholinergic
The research paper suggested that the risk of dementia is higher in people consuming strongest type of anticholinergic
Treatment-emergent adverse events consisted largely of transient mild to moderate anticholinergic
effects, which seldom led to study discontinuation.
Alt is likely the drug you take is in a class called anticholinergics
. These drugs work by blocking a brain chemical called acetylcholine, which plays a role in a range of body functions including muscle contraction, memory, attention, and the regulation of the endocrine system.
M/A is not limited to individuals with psychotic disorders.
The specific classes of anticholinergics
red-flagged in the study included medications for Parkinson's disease and bladder conditions, as well as anticholinergic
Nearly half of Medicare beneficiaries with Parkinson's disease were concurrently prescribed a high-potency anticholinergic
medication and an acetylcholinesterase inhibitor, with higher rates of potential prescribing errors seen among women and Hispanic patients, according to a cross-sectional analysis of Centers for Medicare & Medicaid Services data published in JAMA Neurology
25, 2018 (HealthDay News) -- High-risk anticholinergic
prescriptions are listed for 6.2 percent of visits of older adults, according to a study published in a recent issue of the Journal of the American Geriatrics Society.
Many drugs have anticholinergic
effects, which may be their main therapeutic action, or an additional effect.
THE FOOD AND DRUG Administration has approved glycopyrronium tosylate, an anticholinergic
for the topical treatment of primary axillary hyperhidrosis in adults and children aged 9 years and older.